Biventricular implantable cardioverter-defibrillator device placement in patients with hostile tricuspid valve anatomy: two case reports and review of the literature. Issue 10 (23rd August 2020)

• Record Type: Journal Article
• Authors: Maskoun, Waddah; Raad, Mohamad; Khan, Arfaat; Mando, Ramy; Homsi, Mohamed
• Is Part Of: Europace. Volume 22:Issue 10(2020)
• Page Start: 1520
• Page End: 1525
• Publication Date: 2020-08-23
• Subjects: Tricuspid valve -- Middle cardiac vein -- Biventricular implantable cardioverter-defibrillator; Arrhythmia -- Treatment -- Periodicals; Cardiac pacing -- Periodicals; Catheter ablation -- Periodicals; Heart -- Physiology -- Periodicals; Electrophysiology -- Periodicals; 617.4120645
• DOI: 10.1093/europace/euaa177
• Languages: English
• ISSNs: 1099-5129

Abstract

Abstract: Aims: Right ventricular (RV) lead placement can be contraindicated in patients after tricuspid valve (TV) surgery. Placement of the implantable cardiac-defibrillator (ICD) lead in the middle cardiac vein (MCV) can be a viable option in these patients who have an indication for biventricular (BiV) ICD. We aim to describe the case of two patients with MCV lead placement and provide a comprehensive review of patients with complex TV pathology and indications for RV lead placement. Methods and results: We describe the cases of two patients with TV pathology unsuitable for the standard transvenous or surgical RV lead placement and undergoing BiV ICD implantation. Their characteristics, procedure, and outcomes are summarized. The BiV ICD was successfully placed with the RV lead positioned in the MCV in both patients. The procedures had no complications and were well-tolerated. On follow-up, both patients had appropriate tachytherapy with no readmissions for heart failure or worsening of cardiac function. Conclusion: Right ventricular lead placement of BiV ICD in the MCV can be an excellent alternative in patients with significant TV pathology and poor surgical candidacy.